Sichenzia Ross Friedman Ference LLP Represents Trovagene, Inc. on $40.3M Public Offering of Common Stock
Press Release – New York, NY – July 22, 2015—New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Trovagene, Inc. (NASDAQ: TROV), a company focused on the research and development of precision cancer monitoring technology, on an underwritten public offering consisting of 4,600,000 shares of the Company’s common stock priced to the public at $8.75 per share. Trovagene raised approximately $40.3 million in gross proceeds.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey Fessler and Tara Guarneri-Ferrara. Piper Jaffray & Co. and Leerink Partners LLC acted as the underwriters for the offering. Additionally, Janney Montgomery Scott LLC, Cantor Fitzgerald & Co. and Maxim Group LLC acted as co-managers for the offering.
- Sichenzia Ross Ference LLP Represents High Tide Inc. in the $8.0 million acquisition of Smoke Cartel, Inc. - January 25, 2021
- Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $6.56 Million Registered Direct Offering - January 25, 2021
- Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $24 Million Upsized Public Offering of Common Stock - January 22, 2021